Cargando…
Including Information on Overdiagnosis in Shared Decision Making: A Review of Prostate Cancer Screening Decision Aids
Background. Overdiagnosis is an accepted harm of cancer screening, but studies of prostate cancer screening decision aids have not examined provision of information important in communicating the risk of overdiagnosis, including overdiagnosis frequency, competing mortality risk, and the high prevale...
Autores principales: | Pathirana, Thanya I., Pickles, Kristen, Riikonen, Jarno M., Tikkinen, Kari A. O., Bell, Katy J. L., Glasziou, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558890/ https://www.ncbi.nlm.nih.gov/pubmed/36247841 http://dx.doi.org/10.1177/23814683221129875 |
Ejemplares similares
-
Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach
por: Pathirana, Thanya, et al.
Publicado: (2019) -
Estimating the magnitude of cancer overdiagnosis in Australia
por: Glasziou, Paul P, et al.
Publicado: (2019) -
Decision aids that really promote shared decision making: the pace quickens
por: Agoritsas, Thomas, et al.
Publicado: (2015) -
Decision Aids for Prostate Cancer Screening Choice: A Systematic Review and Meta-analysis
por: Riikonen, Jarno M., et al.
Publicado: (2019) -
A personalized decision aid for prostate cancer shared decision making
por: Bagshaw, Hilary P., et al.
Publicado: (2021)